All stock reports

PPLPHARMA evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-28T14:01:32.020713+00:00

Metrics

latest_annual_period
2026-03-31
revenue
88690800000.0
net_income
-3259400000.0
operating_cash_flow
13995600000.0
free_cash_flow
5095400000.0
total_assets
179650400000.0
total_liabilities
98024200000.0
total_equity
81626200000.0
cash
12236400000.0
total_debt
56745900000.0
revenue_growth
-0.021180885112018544
earnings_growth
-4.576648743553166
net_margin
-0.036750147704158714
roe
-0.03993080653025622
debt_to_equity
0.6951922299457772
cash_conversion
-4.293919126219549
free_cash_flow_margin
0.057451280177876395
trailing_pe
Not supplied
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
3.1808
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-4a85a3e057b3724dce152e4817afca0479d2b2a6fe6bc5724ebe55bb1aa25b82
Policy
stock-decisions-v1
Evidence bundle hash
c64ba761af7ae5e9ba4d931ac815fb1be756cff289d81b22b909c43519f3c6a1
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 3d5c0cabd3b78daef0d2f363b73e10692fbd2a902ce7fe9269486c3f9960fcc1
  • daily-price: aa5952e238a6b7709b27600e1c1c28235ed98390b7326da41d8051b174c8cfdf
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits